openPR Logo
Press release

Duchenne Muscular Dystrophy Market Report: Size, Share, Trends, Growth, Technology, Analysis And Forecast To 2032

Duchenne Muscular Dystrophy Market

Duchenne Muscular Dystrophy Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

Duchenne Muscular Dystrophy Market Size, Growth Rate, And Forecast
The global duchenne muscular dystrophy market size is expected to grow from $0.98 billion in 2022 to $1.07 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global duchenne muscular dystrophy market size is expected to reach $1.48 billion in 2027 at a CAGR of 8.3%.

Request For Free Sample Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10368&type=smp

Duchenne Muscular Dystrophy Market Drivers
The rise in the prevalence of duchenne muscular dystrophy is expected to propel the growth of the Duchenne muscular dystrophy market going forward. Prevalence is the proportion of individuals affected by a particular disease. The prevalence of Duchenne muscular dystrophy is predominantly among males between the ages of 7 and 13 years. Due to a defective gene for dystrophin, DMD has become increasingly prevalent, which may be linked to factors including improved diagnosis, genetic mutations, and environmental factors.

Learn More On The Duchenne Muscular Dystrophy Market Report Here:
https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report

Duchenne Muscular Dystrophy Market Segments
1) By Therapy: Mutation Suppression, Exon Skipping Approach
2) By Therapeutic Class: Molecular Based Therapies, Steroid Therapy
3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Duchenne Muscular Dystrophy Market.

Check Out Buying Options For The Duchenne Muscular Dystrophy Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10368

Duchenne Muscular Dystrophy Market Key Players
Major competitors in the Duchenne Muscular Dystrophy Market include Bristol Myers Squibb Company, FibroGen Inc., Italfarmaco SpA, NS Pharma Inc., Pfizer Inc., PTC Therapeutics, Santhera Pharmaceuticals, Sarepta Therapeutics Inc., BioMarin Pharmaceutical Inc., Eli Lilly and Company, GSK plc., Nippon Shinyaku Co Ltd., Acceleron Pharma, Inc., Akashi Therapeutics Inc., and Capricor Therapeutics Inc

The Business Research Company's "Global Duchenne Muscular Dystrophy Market Report 2023" is a comprehensive report of the market, covering over 60 geographies and high level market segmentation per geography. The section on regional and country breakdowns examines the market in each geography as well as market size by region and country. Furthermore, it evaluates the market's historical and projected growth and identifies significant trends and strategies that businesses can use to expand their operations.

The Table Of Content For The Duchenne Muscular Dystrophy Market Include:
1. Executive Summary
2. Duchenne Muscular Dystrophy Market Characteristics
3. Duchenne Muscular Dystrophy Market Trends And Strategies
4. Duchenne Muscular Dystrophy Market - Macro Economic Scenario
5. Duchenne Muscular Dystrophy Market Size And Growth
.......
26. Africa Duchenne Muscular Dystrophy Market
27. Duchenne Muscular Dystrophy Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Duchenne Muscular Dystrophy Market
29. Duchenne Muscular Dystrophy Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Duchenne Muscular Dystrophy Market Report: Size, Share, Trends, Growth, Technology, Analysis And Forecast To 2032 here

News-ID: 3117428 • Views:

More Releases from The Business research company

Surgical Meshes Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Surgical Meshes Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Surgical Meshes Market Size By 2025? In the past few years, the market size of surgical meshes has seen significant growth. It is projected to expand from $2.03 billion in 2024 to $2.18 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 7.3%.
Rehabilitation Equipment Market Poised to Hit $23.97 Billion by 2029 with Accelerating Growth Trends
Rehabilitation Equipment Market Poised to Hit $23.97 Billion by 2029 with Accele …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rehabilitation Equipment Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a significant growth in the size of the rehabilitation equipment market. Projected to increase from $17.36 billion in 2024, it is expected to reach $18.49 billion in 2025, with a compound annual
Future of the Pediatric Neurology Device Market: Strategic Analysis and Forecast to 2034
Future of the Pediatric Neurology Device Market: Strategic Analysis and Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pediatric Neurology Device Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pediatric neurology devices has seen significant expansion in recent years, climbing from $2.5 billion in 2024 to an anticipated $2.65 billion in 2025, reflecting a compound annual growth rate (CAGR)
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: Innovative Products Boosting Profitability in the Orthokeratology Lens Market
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Orthokeratology Lens Market Through 2025? The market for orthokeratology lenses has seen a significant increase in size over recent years. It's projected to expand from $2.56 billion in 2024 to $2.75 billion in 2025, with a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Duchenne

Duchenne Muscular Dystrophy: Core Growth Enabler in the Rising Prevalence Of Chr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Duchenne Muscular Dystrophy Industry Market Size Be by 2025? The market size for Duchenne Muscular Dystrophy has shown significant expansion recently, burgeoning from $1.16 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The impressive growth in the
Emerging Trends Influencing The Growth Of The Duchenne Muscular Dystrophy (DMD) …
The Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Expected to Be by 2034? In recent times, the market size for Duchenne Muscular Dystrophy (DMD) therapeutics has seen a significant
Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market in 2025: Bit B …
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Expected to Be, and What Will Its Growth Rate Be? The Duchenne muscular dystrophy (DMD) therapeutics market will grow from $11.95 billion in 2024 to $16.45 billion in 2025, at a CAGR of 37.6%. The growth is attributed to the increasing prevalence of Duchenne muscular dystrophy, rising awareness of treatment options, healthcare spending, and government initiatives. The Duchenne muscular dystrophy (DMD) therapeutics
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market